Clinical observation of Wenzhong Jiangni San acupoint application in the prevention and treatment of breast cancer chemotherapy-induced nausea and vomiting

The first affiliated hospital of Henan University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Breast cancer was diagnosed by pathological examination;
•(2) Patients with indications for chemotherapy who intend to undergo chemotherapy with AC;
•(3)The patients were 18-75 years old, had no vital organ dysfunction, and had an ECOG-PS score of 0-2;
•(4) Estimated survival time > 6 months;
•(5) Approved by the ethics committee, informed and voluntary to accept treatment, signed chemotherapy consent and informed consent.

•(1) Those who do not meet the criteria for inclusion;
•(2) Vomiting from other causes prior to chemotherapy;
•(3) Have mental illness;
•(4) Patients and their family members do not agree to participate in this study, do not sign informed consent, poor compliance, cannot cooperate to complete this study;
•(5) Patients who also participated in other clinical research topics;
•(6) Patients with severe allergies to the study drugs (TCM, placebo, acupoint dressing, and 5-HT3RA);
•(7) Pregnant or lactation patients;
•(8) Change the chemotherapy regimen due to the progression of the disease during chemotherapy;
•(9) Patients who received any antiemetic medication in the 24 hours prior to chemotherapy;
•(10) Other circumstances that the project team deems necessary to exclude.

发起方

The first affiliated hospital of Henan University of Chinese Medicine